Andere talen EQL Pharma AB

Aandelen

EQL

SE0005497732

slotkoers NORDIC GROWTH MARKET Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
43,3 ^SEK	+0,70%		+1,41%	+29,64%

22/04	EQL Pharma AB (Publ) kondigt de lancering van Mellozzan (Melatonine) in Duitsland en Oostenrijk aan	CI
13/02	EQL Pharma AB (publ) geeft verkoopprognose voor het jaar 2023/24	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Mellozzan[® ](melatonin) launched in Germany and Austria	22/04
EQL Pharma AB Announces Mellozzan Launched in Germany and Austria	22/04
Mellozzan[® ](melatonin) have gained marketing approval in the UK	14/03
Nomination committee for the 2024 Annual General Meeting	16/02
EQL Pharma: Q3 numbers supportive of inflection point	14/02
Interim Report April - December 2023	13/02
EQL Pharma AB Provides Sales Guidance for the Year 2023/24	13/02
EQL Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02
Invitation to presentation in connection with EQL Pharma's quarterly report, third quarter, 2023/24	30/01
EQL Pharma: Growth and margin inflection point – Q3(23/24) preview	24/01
EQL Pharma: A repeat prescription for growth	23/11
EQL Pharma again appointed Gazelle company in Skåne by Dagens Industri and once again places itself in 6th place out of 98 Skåne Gazelles	20/11
Interim Report April - September 2023	17/11
EQL Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	17/11
Invitation to presentation in connection with EQL Pharma's quarterly report, second quarter, 2023/24	06/11
EQL Pharma Plans 2024 Launch of Melatonin Product in Germany, Austria After Marketing Approvals	06-10-23
Mellozzan[® ](melatonin) have gained marketing approval in Germany and Austria	06-10-23
EQL Pharma AB Announces its Mellozzan Gains Marketing Approval by Health Authorities in Germany and Austria	06-10-23
EQL Pharma : Annual report 2022/2023	25-08-23
Bulletin from the annual general meeting in EQL Pharma AB on 17 August 2023	17-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen EQL Pharma AB

Aandelen

EQL

SE0005497732

Andere talen

Filters